ANI Pharmaceuticals, Inc. (ANIP) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

ANI Pharmaceuticals, Inc. (ANIP) closed at USD 70.16 on 2026-10-14, a change of -24.8 % over the past year, with a market capitalization of USD 1.66B.

ANI Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

ANI Pharmaceuticals, Inc. key figures

Previous close

USD 70.16 (2026-10-14)

1-year change

-24.8 %

Market cap

USD 1.66B

Enterprise value

USD 1.8B

P/E ratio (trailing)

15.78

P/E ratio (forward)

7.11

EPS (trailing)

4.58

EPS (forward)

10.17

PEG ratio

1.74

Price to book

2.59

Revenue growth

25.9 %

Earnings growth

191.1 %

Dividend per share (trailing)

0.00

Short ratio

8.36

Employees

970

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for ANI Pharmaceuticals, Inc. and compare it with other stocks.